A detailed history of Stifel Financial Corp transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 20,076 shares of VYGR stock, worth $110,819. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,076
Previous 20,030 0.23%
Holding current value
$110,819
Previous $158,000 25.95%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.77 - $9.27 $265 - $426
46 Added 0.23%
20,076 $117,000
Q2 2024

Aug 13, 2024

BUY
$7.42 - $10.54 $18,772 - $26,666
2,530 Added 14.46%
20,030 $158,000
Q1 2024

May 13, 2024

BUY
$7.15 - $10.84 $51,086 - $77,451
7,145 Added 69.0%
17,500 $162,000
Q4 2023

Feb 12, 2024

BUY
$6.28 - $8.81 $65,029 - $91,227
10,355 New
10,355 $87,000
Q4 2020

Feb 12, 2021

SELL
$7.15 - $12.28 $104,826 - $180,037
-14,661 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$10.01 - $13.75 $35,805 - $49,183
-3,577 Reduced 19.61%
14,661 $157,000
Q2 2020

Aug 14, 2020

SELL
$8.05 - $14.21 $13,685 - $24,157
-1,700 Reduced 8.53%
18,238 $230,000
Q1 2020

May 14, 2020

SELL
$6.8 - $14.66 $93,704 - $202,014
-13,780 Reduced 40.87%
19,938 $182,000
Q4 2019

Feb 13, 2020

BUY
$12.82 - $16.85 $99,496 - $130,772
7,761 Added 29.9%
33,718 $472,000
Q3 2019

Nov 13, 2019

SELL
$16.31 - $28.29 $9,688 - $16,804
-594 Reduced 2.24%
25,957 $447,000
Q2 2019

Aug 14, 2019

SELL
$19.18 - $27.88 $74,475 - $108,258
-3,883 Reduced 12.76%
26,551 $723,000
Q1 2019

May 14, 2019

SELL
$8.0 - $19.66 $3,616 - $8,886
-452 Reduced 1.46%
30,434 $582,000
Q4 2018

Feb 13, 2019

SELL
$8.59 - $18.05 $12,618 - $26,515
-1,469 Reduced 4.54%
30,886 $293,000
Q3 2018

Nov 13, 2018

BUY
$17.11 - $21.74 $87,620 - $111,330
5,121 Added 18.8%
32,355 $612,000
Q2 2018

Aug 14, 2018

BUY
$16.76 - $23.92 $194,332 - $277,352
11,595 Added 74.14%
27,234 $534,000
Q1 2018

May 11, 2018

SELL
$16.16 - $31.31 $30,396 - $58,894
-1,881 Reduced 10.74%
15,639 $293,000
Q4 2017

Feb 14, 2018

BUY
$12.26 - $25.88 $214,795 - $453,417
17,520
17,520 $291,000

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $213M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.